Lv31
320 积分 2024-04-17 加入
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
2小时前
已完结
Reprogramming CD22 CAR-T cells in vivo Using CD8-Targeted mRNA-LNPs to Treat Hematological Malignancies
3个月前
已完结
Efficacy and Safety of Dual-Targeting Chimeric Antigen Receptor-T Therapy for Relapsed or Refractory B Cell Lymphoid Malignancies: A Systematic Review and Meta-Analysis
7个月前
已完结
Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models
7个月前
已完结
Engineering Novel CD19/CD22 Dual-Target CAR-T Cells for Improved Anti-Tumor Activity
7个月前
已完结
Dual-target CAR-T cell therapy: A new strategy to improve the therapeutic effect of hematological malignancies
7个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
8个月前
已完结
Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo
8个月前
已完结
In vivo CAR engineering for immunotherapy
9个月前
已完结
CAR T cells produced in vivo to treat cardiac injury
9个月前
已完结
皖公网安备34019202002308
